Chairpersons: Dr. Eric Chevet (Bordeaux, France), Dr. Jean-Ehrland Ricci (Nice, France), Dr. Philippe Juin (Nantes, France)
› Impact of select IRE1alpha somatic mutations in oncogenesis. - Stéphanie Lhomond, Université Bordeaux Segalen, Bordeaux, France
09:15-09:35 (20min)
› The hypoxia-inducible GAPDH activates HIF-1 and promotes aggressiveness of c-Myc-driven B-lymphoma. - Johanna CHICHE, INSERM U1065, Centre Méditerranéen de Médecine Moléculaire, Nice, France
09:35-09:55 (20min)
› Cleaved CD95L promotes cell migration in breast cancers by inducing an EGFR-driven signal. - Marine Malleter, Inserm U1085, IRSET, Rennes, France
09:55-10:15 (20min)
› Ionizing radiations sustain Glioblastoma cell plasticity to a stem-like phenotype : a new pathway of radioresistance? - Anthony LEMARIE, INSERM UMR 1037, Centre de recherches en cancérologie de Toulouse, France
10:15-10:35 (20min)
Cell death and immune response Chairpersons: Dr. Frédéric Rieux-Laucat (Paris, France), Dr. Nicolas Bidère (Paris, France)
14:00 - 16:00 (2h)
Cell death and immune response
Chairpersons: Dr. Frédéric Rieux-Laucat (Paris, France), Dr. Nicolas Bidère (Paris, France)
› Caspase-8, cell death mechanisms, autoimmunity and cancer - Razqallah Hakem, University Health Network, Toronto University, Canada
14:00-14:30 (30min)
› LUBAC participates to antigen receptor-mediated NF-κB activation and survival of lymphoma cells - Sonia Dubois, INSERM U1014, Paris, France
14:30-14:50 (20min)
› Somatic RAS Mutations : From Auto-Immunity To Leukemia - Frédéric Rieux-Laucat, INSERM U768, Paris, France
14:50-15:10 (20min)
› Role of Tumor Necrosis Factor-alpha on CD8-dependent immune responses during melanoma progression - Bertrand florie, INSERM UMR 1037, Centre de Recherches en Cancérologie de Toulouse, France
15:10-15:30 (20min)
